Summary: Liquid biopsies are emerging as powerful minimally invasive approaches that have the potential to solve several long-standing problems spanning the continuum of cancer care: early detection of cancer, minimal residual disease tracking, and refinement of the heterogeneity of clinical responses together with therapeutic response monitoring in the metastatic setting. Existing challenges driven by technical limitations and establishment of the clinical value of liquid biopsies represent fields of active research that call for convergence science approaches to bridge scientific discovery with clinical care.

中文翻译：

---

突破液体活检的界限以实现早期精准干预


摘要：液体活检正在成为一种强大的微创方法，有可能解决癌症治疗过程中几个长期存在的问题：癌症的早期检测、微小残留病的追踪以及临床反应异质性的细化和治疗转移环境中的反应监测。由技术限制和液体活检临床价值的确立所带来的现有挑战代表了活跃的研究领域，这些领域需要融合科学方法来将科学发现与临床护理联系起来。